U.S. Life Sciences Stock News

Why Apogee Therapeutics Stock Is On Investors’ Radar Apogee Therapeutics (APGE) recently attracted attention after its strong past 3 months return, which contrasts with relatively flat moves over the past week and month. Investors are weighing that performance against its current clinical stage profile. See our latest analysis for Apogee Therapeutics. At a latest share price of US$134.09, Apogee Therapeutics has seen share price momentum cool in the very short term. However, its 90 day share...

The potential US$400b merger talks between AstraZeneca and Bristol Myers Squibb have thrown a fresh spotlight on the ecosystem that sits behind every big pharma deal. Advisory, legal, and M&A service providers that focus on healthcare can feel the ripple effects of this kind of headline, even while AstraZeneca shares themselves react sharply, with a drop of over 7% on the news. This article looks at how this development might influence deal related activity and what that could mean for...

What RPC’s Latest Quarter Tells You RPC (RES) drew fresh attention after second quarter 2026 results outpaced market revenue expectations and the company lifted its capital spending outlook, while also reaffirming a regular quarterly cash dividend. Management pointed to stronger Technical Services performance, improved job mix, and contributions from advanced downhole tools and coiled tubing investments as key supports for the quarter, even as some other service lines softened. See our latest...

HF Sinclair (DINO) is in focus after reporting second quarter results that included higher sales, stronger net income and a 5% dividend increase, along with plans to wind down base oil refining in Mississauga. See our latest analysis for HF Sinclair. HF Sinclair’s share price has gained 26.06% over the past 30 days and 95.24% year to date, with a 124.01% 1-year total shareholder return that points to strong recent momentum rather than a gradual build. If recent earnings and restructuring...

In July 2026, Alpha Tau Medical announced that its Alpha DaRT device combined with pembrolizumab produced a 100% objective response rate and a median overall survival of 18.2 months in a small clinical study of elderly patients with locally advanced or metastatic head and neck squamous cell carcinoma, with only mild device-related side effects reported. An interesting aspect of this trial is that it met its pre-set efficacy bar so convincingly that enrollment was stopped early for success...

New US Section 301 tariffs are reshaping global supply chains and changing how cross border costs hit company profit margins. For investors, this is less about headline politics and more about which stocks sit on the right or wrong side of these new trade rules. Some businesses gain breathing room because key imports are exempt. Others face rising input costs and pressure on earnings. This article walks through three stocks that are exposed to the latest tariff moves, with one potentially...

Teradata stock has delivered a 54.1% return over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks still point to the shares trading at a discount to their assessed worth. Over the last 12 months Teradata is up 54.1%, which puts recent momentum in sharp contrast with earlier multi year share price weakness. Teradata’s push into enterprise AI, highlighted by new customer engagements in global financial services, can support expectations...

Mondelez International recently reported second-quarter 2026 results showing higher sales of US$9,355 million and higher net income of US$1,548 million year on year, alongside an ongoing share buyback and a nationwide recall of Cadbury Dairy Milk Oreo Candy bars in the US due to undeclared pistachio allergens. At the same time, the company is using innovation such as cell‑cultured chocolate technology and limited‑edition CHIPS AHOY! Mystery Cookies to respond to cocoa cost volatility and...

The Morning Bull - US Market Morning Update Monday, Aug, 3 2026 US stock futures are pointing higher this morning, with S&P 500 contracts up around 0.6%. The move comes as US 10 year Treasury yields hover near 4.7% to 4.8%, which keeps borrowing costs for mortgages, credit cards and corporate debt relatively expensive as the Federal Reserve talks tough on inflation. At the same time, a key consumer confidence survey from Michigan sits at 55.2 for July, a five month high, and one year...

TAL Education Group (NYSE:TAL) has attracted fresh investor attention after reporting first quarter earnings on July 30, 2026, alongside an extension of its share repurchase program through late July 2027. See our latest analysis for TAL Education Group. TAL Education Group's latest earnings release and buyback extension have come alongside strong share price momentum, with a 21.36% 7 day share price return and a 25.00% 30 day share price return. The 5 year total shareholder return of 114.04%...

First National Bank Alaska stock barely flinched after earnings, with the share price essentially flat. This suggests investors saw nothing to force a rethink of the long term thesis. The bank that markets know for steady profitability again reported double digit trailing earnings growth and a net profit margin in the high 30s. That combination keeps the core story intact. The real tension for you as an investor now lies between that earnings power and a stock that trades at a P/E of 12.7x...

AZZ stock performance snapshot AZZ (AZZ) has gained attention after a strong year-to-date move, while recent returns have been more muted. The stock last closed at $144.72, with total revenue of $1.68b and net income of $198.36m. See our latest analysis for AZZ. AZZ’s 1-day share price return slipped 0.17% and the 7-day share price return declined 3.46%. However, the year-to-date share price return of 31.88% and 1-year total shareholder return of 37.04% indicate momentum that has built over a...

Viasat stock reaction: recent performance triggers fresh look Viasat (VSAT) has drawn investor attention after a mixed spell in its share performance, with gains over the past 3 months but a decline over the past month and a small pullback in the latest session. See our latest analysis for Viasat. At around US$76.93 per share, Viasat has seen short term momentum cool slightly after a recent run. The company has recorded a strong year to date share price return of 104.44% and a very large 1...

Amazon.com (AMZN) is back in focus after a new consumer lawsuit alleged the retailer sold Orgain protein powder containing harmful levels of heavy metals, raising fresh questions about product oversight on its marketplace. See our latest analysis for Amazon.com. The latest lawsuit lands just as Amazon.com’s share price has surged to US$271.58, with a 1-day share price return of 15.32% and a year-to-date share price return of 19.90%. The 3-year total shareholder return of 94.58% and 5-year...

Recent performance and business snapshot Global Ship Lease (GSL) has drawn investor attention after a period of solid share price moves, with the stock up about 17% over the past month and roughly 9% in the past 3 months. The company owns and charters a fleet of 71 mid sized and smaller containerships, generating US$757.04 million in revenue and US$377.35 million in net income from its shipping operations. See our latest analysis for Global Ship Lease. At a share price of US$44.34, Global...

Q1 earnings beat sets the stage for closer scrutiny LifeStance Health Group (LFST) recently reported Q1 revenue of $403.5 million, up 21.2% year on year, exceeding analyst expectations by 4.2% and giving investors fresh numbers to reassess the stock. The quarter also brought net income growth of $13.5 million and a 48% increase in Adjusted EBITDA. At the same time, LifeStance Health offered the weakest guidance update among its peers, which may temper sentiment despite the strong headline...

3M stock has more than doubled over the past three years while current valuation checks still suggest the shares may trade below an estimate of intrinsic value. This puts the recent enthusiasm in focus for investors looking at what they are paying for that recovery. Over the past three years, 3M has delivered a return of about 119.3%, which puts recent gains front and center for anyone considering the current price tag. The partnership to supply optical technology for Microsoft Azure AI data...

Service Corporation International (SCI) has come into focus after reporting second quarter 2026 results that modestly exceeded market expectations, with management reaffirming full year earnings guidance and raising its adjusted operating cash flow midpoint. See our latest analysis for Service Corporation International. The latest earnings report has coincided with a clear pick up in interest in Service Corporation International, with an 11.65% year to date share price return and a 46.24%...

Ameren Corporation recently reported past second-quarter 2026 results showing revenue of US$2,092 million versus US$2,221 million a year earlier, while net income rose to US$314 million and diluted earnings per share from continuing operations increased to US$1.13 from US$1.01. Alongside reaffirming its 2026 earnings guidance of US$5.25 to US$5.45 per share, Ameren highlighted a long-term US$71.00 billion infrastructure pipeline aimed at supporting power-hungry data centers and other...

In the past six months, The Marzetti Company reported softer quarterly results alongside only 1.8% annualized revenue growth over three years, drawing attention to its limited distribution reach and low 23.5% gross margin. These figures point to underlying questions about the company’s structural profitability, as it competes in a consumer staples space where many peers operate with higher margins. We’ll now examine how concerns over Marzetti’s slow sales growth and weak gross margins may...

Income investors are hunting for reliability as inflation, interest rate expectations and energy driven price swings keep markets on edge. The Dividend Powerhouses screener focuses on companies with dividend yields above 5% that are well covered, growing and stable. This approach can help you seek steady cash flow without having to chase every market move. In this article you see three stocks that currently pass this filter. The focus is on why their income profile stands out, how that might...

Cathay General Bancorp (CATY) reported second quarter 2026 results that highlighted movements in net interest income, net income and earnings per share from continuing operations, giving you fresh financial data to assess the stock. See our latest analysis for Cathay General Bancorp. The latest second quarter update arrives after a strong run in Cathay General Bancorp’s stock, with a 90 day share price return of 12.02% and a 1 year total shareholder return of 44.91% hinting at building...

WD-40 (WDFC) has drawn investor attention after recent share price moves, with the stock closing at $227.14. The company’s household and maintenance brands reach customers across the Americas, Asia-Pacific, and Europe, India, the Middle East and Africa. See our latest analysis for WD-40. Recent trading has been softer, with the 30 day share price return down 5.92% and the 7 day move also lower. However, WD-40 still shows a 15.44% year to date share price gain and a 7.55% 1 year total...

In the past quarter, American Water Works Company, Inc. reported higher Q2 2026 sales of US$1,355 million and net income of US$315 million, raised first-half figures versus a year earlier, and its board affirmed a quarterly dividend of US$0.8950 per share payable on September 1, 2026. Management also emphasized that the company remains “well positioned for growth through acquisitions” across multiple states in 2026, underlining how bolt-on deals and regulatory progress are central to its...